CoronaryAtlas logo
CoronaryAtlas
Albumin
Pathway / Off-pathway / systemic markers

Albumin

protein

Albumin reduction in acute MI reflects systemic inflammation and oxidative stress, serving as a generic stress and hemodynamic marker.

Pathway placement
Cascade stepOff-pathway / systemic markers
Confidencemedium
RationaleSystemic acute-phase and oxidative stress marker; inverse predictor of vascular events.
Also acts inVascular inflammation
Druggability
Not assessed (no mapped human gene target).

Type I vs non-Type I discrimination

ScoresIndeterminate
R — rupture / Type-I
67
C — non-Type-I
48
A — assay feasibility
84
E — evidence strength
52
T1DI (composite)
26
Specificity differential (R−C)+19.1
Non-Type-I axis panel
Does this marker also move in each non-Type-I setting? mag 0–3; higher means less Type-I-specific. n/a = no evidence retrieved, which is not the same as no change.
2sepsis / systemic inflammationmag 2
2anemia / acute blood lossmag 1
2hypovolemia / dehydrationn/a
2tachyarrhythmian/a
2hypoxemia / respiratory failuremag 1
2hypertensive emergencyn/a
2high-demand / peri-operative stressmag 1
3sudden cardiac deathmag 1
4aPCI-related periproceduraln/a
4bstent thrombosismag 2
4cin-stent restenosismag 2
5CABG-relatedn/a
Coverage: 7/12 axes with evidence
Tier: deep-scored (abstract-extracted) · 13 supporting references. See the discrimination table for all markers.

Assay & specimen

Validated clinical assay
Specimen
Serum or plasma; urine (microalbumin)
Collection tube
Serum separator (gold/red-top, SST) · Lithium heparin (green-top) · Sterile urine container
Method / principle
Dye-binding (BCG/BCP) or immunoturbidimetric (urine)
Reagent / substrate
Bromocresol green/purple; anti-albumin latex for urine
Platform
Automated analyzer
Turnaround · availability
Routine · Universal

Literature evidence(7)